What's My OB-GYN Practice Worth?
We value your practice the way a private-equity or strategic buyer will, from real adjusted earnings up, so you know your range before anyone else does.
Run the estimator →
Home / Who We Serve / Women's Health
Tier-1 Specialty · Sell-Side M&A
Your Women's Health Practice Is Priced on Payor Mix, Not Just Patient Volume.
A well-run OB-GYN practice is valued on the profit it repeats and the strength of its payor contracts, and we help you see that number before any buyer does.
What's your women's health practice actually worth?
A confidential ballpark in under two minutes, no email required.
Why Women's Health Is Different
Why a women's health practice is valued differently.
A women's health practice does not trade on revenue alone. The lever that moves your multiple most is payor mix: commercial-payor concentration and contract strength tell a buyer how predictable your cash flow really is, and a Medicaid-heavy book is read very differently from a commercially-weighted one. Layer cash-pay, aesthetic-adjacent services on top, such as menopause and hormone optimization, and you add the kind of recurring, out-of-network revenue that buyers in this sector pay a premium to own.
Payor Mix & Contract Strength
Commercial-payor concentration and the terms inside your contracts are the single biggest swing on your multiple. We assess your payer contracts, fee schedules, and billing practices to show buyers a revenue cycle built for stability, not surprises.
Cash-Pay Aesthetic-Adjacent Upside
Menopause and hormone work, wellness services, and other out-of-network offerings add recurring cash-pay revenue that reimbursement-bound practices cannot match. We position this mix as expansion headroom a buyer can underwrite, not a footnote.
Loyal Patients & Lifespan Care
Women's health practices carry loyal patient bases and the ability to provide care across a patient's lifespan, from preventive and gynecological care through midlife transitions. That continuity is recurring demand, and recurring demand earns a higher multiple.
Compliance as a Selling Point
A clean regulatory and compliance framework removes risk from a buyer's diligence. We turn your compliance record into a reason to pay more rather than a concern that drags the deal, and we show how your EMR, scheduling, and patient-engagement systems make the practice transferable.
| Medicaid-heavy payor mix, reimbursement-bound only | Lower end of the range | Selective |
| Balanced commercial payor mix, stable contracts | Mid-range | Strong |
| Commercially-weighted plus cash-pay aesthetic-adjacent revenue | Top of the range | Competitive |
Directional only. Because no published women's-health multiple exists, we apply a clearly labeled general medical-practice proxy of roughly 5x to 10x adjusted earnings, with platform-scale, commercially-weighted practices reaching the upper end and single-provider, reimbursement-bound practices nearer the lower end. Payor mix is the swing lever and is a medium-confidence estimate until your real contracts are reviewed. The band is a labeled proxy, not an Aesthetic Brokers figure or an offer; your real number comes from a confidential, practice-specific analysis of your earnings and payor contracts.
How Value Is Built
How a women's health multiple is built.
The pattern is consistent: payor mix and cash-pay share move a women's health practice from a reimbursement-bound book to an investable platform. Your confidential report normalizes your earnings, reviews your real payor contracts, and shows exactly which moves widen the spread in your favor.
Run my numbers →See Your Number First
Know your number before anyone else does.
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
$3.0M
Estimated enterprise value
$1.4M – $4.7M
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
- Build recurring revenue past 30% of sales
- Reduce owner-performed treatment dependence
- Clean, normalized three-year financials
What lowers your number
- Owner performs the majority of clinical work
- Recurring revenue under 15% of sales
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
Women's Health Sellers Ask
Everything that moves your number, in plain English.
How Payor Mix Moves Your Number
Commercial versus Medicaid weighting and your contract terms can move your multiple more than revenue does, and we show you exactly where you stand.
Read your readiness →Cash-Pay & Aesthetic-Adjacent Services
Menopause, hormone, and wellness lines add recurring out-of-network revenue, and we position that upside as growth a buyer will pay for today.
See the upside →Platform vs. Add-On Acquisition
Whether buyers see you as a regional platform or a bolt-on changes your multiple meaningfully, and we help you understand which story your practice tells.
Test the impact →Confidentiality & Protecting Your Staff
We run every process under strict confidentiality so your team, patients, and referral sources learn nothing until you decide they should.
Our confidentiality method →Selling a Multi-Site Women's Health Group
Integrated networks across multiple locations are valued on the real performance of each site and the strength of central administration, not a flattened average.
Scale-to-sell playbook →Women's Health Track Record · Anonymized
Discretion is the proof.
Single-location OB-GYN
$00.0M
Sell-side advisor
Commercially-weighted Women's Health
$00.0M
Sell-side advisor
Multi-site Women's Health Group
$00.0M
Sell-side advisor
OB-GYN + Cash-Pay Wellness
$00.0M
Sell-side advisor
Tombstone values redacted by design. The published board uses Aesthetic Brokers' verified, client-consented anonymized deals only.
Specialist Perspective
What Makes Selling a Women's Health Practice Different
A women's health practice is not valued the same way a med spa or a surgical suite is. The buyer universe is different, the deal risks are different, and the things that move your number are specific to this sector. A generalist broker will not see them the same way a sell-side team focused on medical aesthetics and specialty health does.
Payor Mix Is the Primary Value Lever
In most practice verticals, revenue volume drives the first conversation. In women's health, buyers look at the composition of that revenue before they look at the size of it. A commercially-weighted payor mix with strong contract terms tells a buyer the cash flow is predictable and priced correctly. A Medicaid-heavy book raises a different set of questions about margin sustainability and growth potential. Two practices at identical revenue can sit in meaningfully different parts of the valuation range based on payor mix alone. Generalist brokers frequently normalize revenue without surfacing this distinction, which leaves money in the room a specialist would have captured.
Cash-Pay and Aesthetic-Adjacent Services Are Not a Side Note
Women's health practices that have moved into menopause management, hormone optimization, wellness panels, or other out-of-network offerings have built a revenue stream that reimbursement-bound practices cannot replicate. A buyer sees that as growth headroom they can underwrite, not just additional top-line. It reduces dependence on payor negotiations and adds a recurring cash-pay base that is priced differently from insurance revenue. The positioning matters: a generalist will often list these services without framing the recurring revenue story they represent. We position them as the expansion opportunity they actually are.
Lifespan Care Creates a Different Kind of Patient Loyalty
A women's health practice can care for the same patient through preventive visits, gynecological care, pregnancy, and midlife transitions. That continuity is not common across most medical-aesthetic verticals. Buyers focused on building platforms around women recognize it as recurring demand with a naturally long patient relationship lifecycle. The depth of that patient base, the referral patterns it generates, and the scope of services a practice can add over time all factor into how a buyer underwrites your business. We surface that story in terms buyers in this sector actually use to price an acquisition.
What Lowers the Multiple: Risks That Generalists Miss
Provider concentration is the most common value depressant in women's health transactions. If the selling physician is the primary reason patients stay and referrals come in, a buyer will adjust the valuation to reflect the risk that both leave with the owner. A second pressure point is a heavy reliance on a single payor or a set of contracts that are due for renewal at close. Compliance gaps, including documentation standards and billing accuracy under specialty-specific codes, surface in diligence and affect both price and structure. We identify these before a buyer does, giving you the option to address them or present them in context rather than watching them erode the offer late in the process.
The Specialist Difference
We know which buyer types are actively building women's health platforms, what they weight in diligence, and how your payor contracts, ancillary mix, and patient demographics read to them in a competitive process. We do not publish an invented multiple for this vertical because the honest answer is that your real number depends on those specific inputs. What we can tell you, from closed transactions in this sector, is that the gap between a well-prepared sale and an unprepared one is material, and it is almost always explained by who ran the process.
Women's Health Sale FAQ
Straight answers, before you commit to anything.
A women’s health practice is valued on its adjusted earnings, usually EBITDA, with a multiple applied on top. The largest swing on that multiple is payor mix: commercially-weighted, predictable revenue earns more than a Medicaid-heavy book. Cash-pay, aesthetic-adjacent services such as menopause and hormone care add recurring upside, which is why two practices with the same revenue can be worth very different amounts.
Payor mix tells a buyer how predictable and durable your cash flow is. Commercial-payor concentration and strong contracts signal stable, well-priced revenue, while a Medicaid-heavy book is read as lower-margin and harder to grow. Because this lever moves the multiple more than top-line revenue does, we assess your payer contracts and fee schedules first to position your revenue cycle for the strongest possible value.
Women’s health practices offer loyal patient bases, recurring revenue, and the ability to provide comprehensive care across a patient’s lifespan. Buyers also value room for ancillary service expansion, growing patient demand across all life stages, and the move beyond traditional OB-GYN into specialized and cash-pay options. Together these qualities make the sector a focus for strategic buyers and private equity firms.
Yes. Cash-pay, aesthetic-adjacent services such as menopause management and hormone optimization add recurring, out-of-network revenue that reimbursement-bound practices cannot match. That mix is read as growth headroom a buyer can underwrite, and it diversifies you away from payor risk. We position these service lines as expansion opportunity rather than a side note, which strengthens both your multiple and buyer competition.
The process typically runs 6 to 12 months from initial valuation to closing, varying with practice complexity and buyer requirements. It stays confidential throughout. We control the flow of information with confidentiality agreements, secure data rooms, and a vetted buyer process, so your staff, patients, and competitors learn nothing until you decide they should. Your value is protected by discretion at every step.
Key value drivers include strengthening your commercial payor mix and contracts, expanding cash-pay and ancillary service lines, optimizing operational efficiency, and reinforcing referral relationships. Maintaining an excellent compliance record, implementing strong financial tracking, and reducing reliance on any single provider all help. Each move makes your revenue more predictable and transferable, which is exactly what raises the multiple a buyer will pay.
Who you work with
You are advised by Bill Walker, not handed to a junior associate.
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceYour women's health practice deserves an uncommon partner.
Start with a confidential, two-minute read on where you stand.